Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

   7,447      
Direct Value   $24,511,741    

Indirect Value

   $3,299,393      
Total Shares   78,772      
Total Value   $27,811,135      


Vertex Pharmaceuticals Inc $24,511,741 Celladon Corp $0 Vertex Pharmaceuticals Inc $24,511,741 Celladon Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-03-29 4 AS $106.30 $8,664,568 D/D (80,500) 99,335 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-25 4 OE $109.14 $545,700 D/D 5,000 38,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-12-09 4 OE $109.14 $545,700 D/D 5,000 38,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-01-08 4 OE $109.14 $545,700 D/D 5,000 41,190 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2014-09-30 4 AS $111.33 $9,690,570 D/D (86,000) 38,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-11-17 4 AS $111.97 $15,004 D/D (134) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-02-18 4 AS $112.62 $670,256 D/D (5,937) 89,984 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-05-15 4 AS $114.37 $13,267 D/D (116) 99,335 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-10-28 4 AS $115.00 $1,380,000 D/D (12,000) 38,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-11-28 4 AS $120.00 $1,440,000 D/D (12,000) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-11-16 4 AS $122.28 $10,394 D/D (85) 78,963 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-23 4 AS $122.78 $638,756 D/D (5,083) 84,901 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-10-30 4 AS $123.34 $745,433 D/D (5,938) 78,963 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-05-15 4 AS $123.85 $16,224 D/D (131) 84,901 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-01-09 4 AS $125.00 $1,500,000 D/D (12,000) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-06-01 4 AS $125.00 $3,812,500 D/D (30,500) 99,335 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-18 4 AS $130.00 $1,560,000 D/D (12,000) 89,984 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-05 4 OE $131.89 $1,761,523 D/D 13,356 48,459 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-06 4 OE $131.89 $88,234 D/D 669 35,772 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-11 4 OE $131.89 $1,406,607 D/D 10,665 45,768 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-20 4 AS $135.08 $1,620,960 D/D (12,000) 89,984 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-10-31 4 AS $142.40 $5,802,084 D/D (40,000) 50,710 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-11-15 4 AS $147.29 $12,225 D/D (83) 50,710 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-02-12 4 AS $149.22 $2,684,411 D/D (17,796) 46,662 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-05-15 4 AS $155.78 $12,930 D/D (83) 46,662 0 -
  193  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us